CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Todos Medical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Todos Medical Ltd
121 Derech Menachem Begin, 30th Floor
Phone: +972 86333964p:+972 86333964 TEL AVIV-YAFO, 6701203  Israel Ticker: TOMDFTOMDF
This company ceased filing statements with the SEC on 7/17/2023.
Filed for Insolvency on 12/22/2023
On 12/22/2023, Todos Medical, Ltd. announced that a Trustee was appointed by the Court of Insolvency in Israel pursuant to an Insolvency Order that was issued for the Company related to a request for Liquidation filed by the Company’s Founder and former Director, President & CEO Rami Zigdon.
Business Summary
Todos Medical Ltd is a Israel-based clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor presence. TBIA analyzes the entire biochemical signatures spectrum including proteins, lipids, nucleic acids and carbohydrates of effected immune cells from peripheral blood, using infrared spectroscopy.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202212/31/2021YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Non-Executive Chairman of the Board Bansidhar S.Mehta 82 2/3/2014 10/26/2005
Chief Financial Officer GaganSawhney 1/1/2017 1/1/2017
Compliance Officer, Company Secretary FlaviaMachado 11/30/2016 11/30/2016
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Provista Diagnostics, Inc. 17301 North Perimeter Drive Scottsdale AZ United States
Todos Medical U.S.A. Inc. 40 Wall Street, Suite 2705 New York NY United States

Business Names
Business Name
Breakthrough Diagnostics Inc.
Breakthrough Diagnostics, Inc.
Corona Diagnostics LLC
4 additional Business Names available in full report.

General Information
Number of Employees: 7 (As of 12/31/2020)
Outstanding Shares: 2,130,423,853 (As of 3/31/2023)
Shareholders: 106
Stock Exchange: OTC
Federal Tax Id: 514437128
Fax Number: +972 39726001


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024